Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy
Clinical trial NCT06418139 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06418139
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-09-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.